Ross Haghighat

Insider Reports History

Entity
Individual
Location
C/O Aduro Biotech, Inc., 626 Bancroft Way, 3 C, Berkeley, CA
Signature
/s/ Kirk Schumacher, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Ross Haghighat:

Stock Role Class Num Shares Value Price $ Report Date Ownership
CHINOOK THERAPEUTICS, INC. Director Common Stock 125K $4.86M $39.03 May 26, 2023 Direct
CHINOOK THERAPEUTICS, INC. Director Stock Option (Right to Buy) 13.3K $347K $26.12 May 26, 2022 Direct
CHINOOK THERAPEUTICS, INC. Director Restricted Stock Units 0 May 26, 2023 Direct

Insider Reports Filed by Ross Haghighat

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2023 2 $0 4 May 31, 2023 Director
EPHY Epiphany Technology Acquisition Corp. Sep 16, 2022 0 $0 3 Oct 4, 2022 Co-Chief Executive Officer, Director
KDNY CHINOOK THERAPEUTICS, INC. May 26, 2022 2 $0 4 May 31, 2022 Director
BIOS BioPlus Acquisition Corp. Dec 2, 2021 0 $0 3 Dec 2, 2021 CEO and CFO, Director
KDNY CHINOOK THERAPEUTICS, INC. Jun 4, 2021 1 $0 4 Jun 7, 2021 Director